Actively Recruiting
Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
Led by University of Valencia · Updated on 2024-04-04
56
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
U
University of Valencia
Lead Sponsor
G
Generalitat Valenciana
Collaborating Sponsor
AI-Summary
What this Trial Is About
POWER Health is a randomized clinical trial with a two-arm parallel design whose objectives are 1) to study metabolic flexibility and autonomic function (both capacities that describe cardiovascular health) in a sample of postmenopausal oncological women vs postmenopausal untreated controls (CT); and 2) to analyze the impact of two different 8-week physical exercise supervised interventions: HIIT training vs strength training focused on muscle power, on both cardiovascular capacities in these populations.
CONDITIONS
Official Title
Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with relapse free-cancer (RFC) or no cancer diagnosis in the last 15 years (control group)
- Aged between 35 and 75 years
- Diagnosed with breast cancer (including ductal carcinoma, invasive carcinoma, triple negative; RFC) or postmenopausal (control group)
- Not participating in any nutritional or dietary intervention
- Physically inactive in the last 3 months or performing less than 600 metabolic equivalents (METS)/week of moderate to vigorous physical activity
- Able and willing to provide informed consent
- No condition that would prevent safe participation in exercise or testing, as determined by research staff
You will not qualify if you...
- Medical contraindication to exercise
- Planned surgery during the intervention
- Regular use of beta blockers or drugs affecting nervous system function
- History of another primary invasive cancer (RFC) or serious chronic illness (control group)
- Cardiac conditions including myocardial infarction or coronary revascularization within 3 months, uncontrolled hypertension (systolic 180 mmHg or diastolic 100 mmHg), uncontrolled arrhythmias, significant valvular disease, decompensated heart failure, or known aortic aneurysm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Physical Activity and Sport Sciences
Valencia, Valencia, Spain, 46010
Actively Recruiting
Research Team
C
Cristina Blasco Lafarga, Tenured Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here